Can-Fite BioPharma Ltd. Increase (Decrease) in Other Accounts Payable
Can-Fite BioPharma Ltd. (CANF) reported Increase (Decrease) in Other Accounts Payable of $133.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-03-26
| Period end | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|
| 2025-12-31 | $133.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | -$470.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $32.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | -$514.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $169.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | -$179.00K 6-K · filed 2024-08-29 | |
| 2022-12-31 | -$130.00K 20-F · filed 2025-04-14 | |
| 2022-06-30 | -$441.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $574.00K 20-F · filed 2024-03-28 | |
| 2021-06-30 | -$22.00K 6-K · filed 2022-08-25 | |
| 2020-12-31 | -$279.00K 20-F · filed 2023-03-30 | |
| 2020-06-30 | -$138.00K 6-K · filed 2021-08-26 | |
| 2019-12-31 | -$512.00K 20-F · filed 2022-03-24 | |
| 2019-06-30 | -$677.00K 6-K · filed 2020-08-27 | |
| 2018-12-31 | $125.00K 20-F · filed 2021-03-25 | |
| 2017-12-31 | $906.00K 6-K · filed 2020-06-01 |